Membrane orientation and subcellular localization of transmembrane protein 106B (TMEM106B), a major risk factor for frontotemporal lobar degeneration

Journal of Biological Chemistry

Volumn 287, Issue 23, 2012, Pages 19355-19365

  Lang, Christina M ^a   Fellerer, Katrin ^a   Schwenk, Benjamin M ^b   Kuhn, Peer Hendrik ^b   Kremmer, Elisabeth ^c   Edbauer, Dieter ^b   Capell, Anja ^a   Haass, Christian ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATPASES; CELLULAR COMPARTMENTS; DNA-BINDING PROTEIN; ENDOPLASMIC RETICULUM; GENOME-WIDE ASSOCIATION; GLYCOSYLATED; HETEROLOGOUS CELLS; INTEGRAL MEMBRANE PROTEINS; INVERSE CORRELATION; LATE ENDOSOMES; MEMBRANE EXTRACTION; MEMBRANE ORIENTATION; N-GLYCOSYLATION SITES; NEURODEGENERATIVE DISORDERS; RISK FACTORS; SINGLE NUCLEOTIDE POLYMORPHISMS; SUBCELLULAR LOCALIZATIONS; TRANS-MEMBRANE PROTEINS;

CELL MEMBRANES; HEALTH RISKS; PATHOLOGY;

PROTEINS;

MEMBRANE PROTEIN; PROGRANULIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; TRANSMEMBRANE PROTEIN 106B; UNCLASSIFIED DRUG;

ARTICLE; CELL TRANSPORT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENDOSOME; FRONTOTEMPORAL DEMENTIA; HUMAN; HUMAN CELL; LYSOSOME; MEMBRANE STRUCTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION;

CELL MEMBRANE; ENDOSOMES; FRONTOTEMPORAL LOBAR DEGENERATION; GENOME-WIDE ASSOCIATION STUDY; GLYCOSYLATION; HEK293 CELLS; HELA CELLS; HUMANS; LYSOSOMES; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TRANSPORT; RISK FACTORS; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 84861722031     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.365098     Document Type: Article

References (52)

1. Graff-Radford, N. R., and Woodruff, B. K. (2007) Frontotemporal dementia. Semin. Neurol. 27, 48-57 (Pubitemid 46239039)
2. Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., Boone, K., Miller, B. L., Cummings, J., and Benson, D. F. (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51, 1546-1554
3. Mackenzie, I. R., Neumann, M., Bigio, E. H., Cairns, N. J., Alafuzoff, I., Kril, J., Kovacs, G. G., Ghetti, B., Halliday, G., Holm, I. E., Ince, P. G., Kamphorst, W., Revesz, T., Rozemuller, A. J., Kumar-Singh, S., Akiyama, H., Baborie, A., Spina, S., Dickson, D. W., Trojanowski, J. Q., and Mann, D. M. (2010) Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol. 119, 1-4
4. Cairns, N. J., Bigio, E. H., Mackenzie, I. R., Neumann, M., Lee, V. M., Hatanpaa, K. J., White, C. L., 3rd, Schneider, J. A., Grinberg, L. T., Halliday, G., Duyckaerts, C., Lowe, J. S., Holm, I. E., Tolnay, M., Okamoto, K., Yokoo, H., Murayama, S., Woulfe, J., Munoz, D. G., Dickson, D. W., Ince, P. G., Trojanowski, J. Q., and Mann, D. M. (2007) Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol. 114, 5-22 (Pubitemid 47029055)
5. Cruts, M., and Van Broeckhoven, C. (2008) Loss of progranulin function in frontotemporal lobar degeneration. Trends Genet. 24, 186-194
6. Mackenzie, I. R., and Rademakers, R. (2007) The molecular genetics and neuropathology of frontotemporal lobar degeneration: recent developments. Neurogenetics 8, 237-248 (Pubitemid 47624449)
7. Neumann, M., Rademakers, R., Roeber, S., Baker, M., Kretzschmar, H. A., and Mackenzie, I. R. (2009)Anew subtype of frontotemporal lobar degeneration with FUS pathology. Brain 132, 2922-2931
8. Urwin, H., Josephs, K. A., Rohrer, J. D., Mackenzie, I. R., Neumann, M., Authier, A., Seelaar, H., Van Swieten, J. C., Brown, J. M., Johannsen, P., Nielsen, J. E., Holm, I. E., FReJA Consortium, Dickson, D. W., Rademakers, R., Graff-Radford, N. R., Parisi, J. E., Petersen, R. C., Hatanpaa, K. J., White, C. L., 3rd, Weiner, M. F., Geser, F., Van Deerlin, V. M., Trojanowski, J. Q., Miller, B. L., Seeley, W. W., van der Zee, J., Kumar-Singh, S., Engelborghs, S., De Deyn, P. P., Van Broeckhoven, C., Bigio, E. H., Deng, H. X., Halliday, G. M., Kril, J. J., Munoz, D. G., Mann, D. M., Pickering-Brown, S. M., Doodeman, V., Adamson, G., Ghazi-Noori, S., Fisher, E. M., Holton, J. L., Revesz, T., Rossor, M. N., Collinge, J., Mead, S., and Isaacs, A. M. (2010) FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol. 120, 33-41
9. Deng, H. X., Chen, W., Hong, S. T., Boycott, K. M., Gorrie, G. H., Siddique, N., Yang, Y., Fecto, F., Shi, Y., Zhai, H., Jiang, H., Hirano, M., Rampersaud, E., Jansen, G. H., Donkervoort, S., Bigio, E. H., Brooks, B. R., Ajroud, K., Sufit, R. L., Haines, J. L., Mugnaini, E., Pericak-Vance, M. A., and Siddique,T. (2011) Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 477, 211-215
10. Watts, G. D., Wymer, J., Kovach, M. J., Mehta, S. G., Mumm, S., Darvish, D., Pestronk, A., Whyte, M. P., and Kimonis, V. E. (2004) Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet. 36, 377-381 (Pubitemid 38437260)
11. Watts, G. D., Thomasova, D., Ramdeen, S. K., Fulchiero, E. C., Mehta, S. G., Drachman, D. A., Weihl, C. C., Jamrozik, Z., Kwiecinski, H., Kaminska, A., and Kimonis, V. E. (2007) Novel VCP mutations in inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia. Clin. Genet. 72, 420-426 (Pubitemid 47570695)
12. Skibinski, G., Parkinson, N. J., Brown, J. M., Chakrabarti, L., Lloyd, S. L., Hummerich, H., Nielsen, J. E., Hodges, J. R., Spillantini, M. G., Thusgaard, T., Brandner, S., Brun, A., Rossor, M. N., Gade, A., Johannsen, P., Sørensen, S. A., Gydesen, S., Fisher, E. M., and Collinge, J. (2005) Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat. Genet. 37, 806-808 (Pubitemid 41077105)
13. Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A. D., Rollinson, S., Cannon, A., Dwosh, E., Neary, D., Melquist, S., Richardson, A., Dickson, D., Berger, Z., Eriksen, J., Robinson, T., Zehr, C., Dickey, C. A., Crook, R., McGowan, E., Mann, D., Boeve, B., Feldman, H., and Hutton, M. (2006) Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442, 916-919 (Pubitemid 44285946)
14. Cruts, M., Gijselinck, I., van der Zee, J., Engelborghs, S., Wils, H., Pirici, D., Rademakers, R., Vandenberghe, R., Dermaut, B., Martin, J. J., van Duijn, C., Peeters, K., Sciot, R., Santens, P., De Pooter, T., Mattheijssens, M., Van den Broeck, M., Cuijt, I., Vennekens, K., De Deyn, P. P., Kumar-Singh, S., and Van Broeckhoven, C. (2006) Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 442, 920-924 (Pubitemid 44285947)
15. Gijselinck, I., Van Broeckhoven, C., and Cruts, M. (2008) Granulin mutations associated with frontotemporal lobar degeneration and related disorders: an update. Hum. Mutat. 29, 1373-1386 (Pubitemid 352774891)
16. Gass, J., Cannon, A., Mackenzie, I. R., Boeve, B., Baker, M., Adamson, J., Crook, R., Melquist, S., Kuntz, K., Petersen, R., Josephs, K., Pickering-Brown, S. M., Graff-Radford, N., Uitti, R., Dickson, D., Wszolek, Z., Gonzalez, J., Beach, T. G., Bigio, E., Johnson, N., Weintraub, S., Mesulam, M., White, C. L., 3rd, Woodruff, B., Caselli, R., Hsiung, G. Y., Feldman, H., Knopman, D., Hutton, M., and Rademakers, R. (2006) Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum. Mol. Genet. 15, 2988-3001 (Pubitemid 44530703)
17. Bird, T. D. (2009) Progranulin plasma levels in the diagnosis of frontotemporal dementia. Brain 132, 568-569
18. Finch, N., Baker, M., Crook, R., Swanson, K., Kuntz, K., Surtees, R., Bisceglio, G., Rovelet-Lecrux, A., Boeve, B., Petersen, R. C., Dickson, D. W., Younkin, S. G., Deramecourt, V., Crook, J., Graff-Radford, N. R., and Rademakers, R. (2009) Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Brain 132, 583-591
19. Ghidoni, R., Benussi, L., Glionna, M., Franzoni, M., and Binetti, G. (2008) Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration. Neurology 71, 1235-1239
20. Sleegers, K., Brouwers, N., Van Damme, P., Engelborghs, S., Gijselinck, I., van der Zee, J., Peeters, K., Mattheijssens, M., Cruts, M., Vandenberghe, R., De Deyn, P. P., Robberecht, W., and Van Broeckhoven, C. (2009) Serum biomarker for progranulin-associated frontotemporal lobar degeneration. Ann. Neurol. 65, 603-609
21. Brouwers, N., Sleegers, K., Engelborghs, S., Maurer-Stroh, S., Gijselinck, I., van der Zee, J., Pickut, B. A., Van den Broeck, M., Mattheijssens, M., Peeters, K., Schymkowitz, J., Rousseau, F., Martin, J. J., Cruts, M., De Deyn, P. P., and Van Broeckhoven, C. (2008) Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease. Neurology 71, 656-664
22. Schymick, J. C., Yang, Y., Andersen, P. M., Vonsattel, J. P., Greenway, M., Momeni, P., Elder, J., Chiò, A., Restagno, G., Robberecht, W., Dahlberg, C., Mukherjee, O., Goate, A., Graff-Radford, N., Caselli, R. J., Hutton, M., Gass, J., Cannon, A., Rademakers, R., Singleton, A. B., Hardiman, O., Rothstein, J., Hardy, J., and Traynor, B. J. (2007) Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis- frontotemporal dementia phenotypes. J. Neurol. Neurosurg. Psychiatry 78, 754-756 (Pubitemid 46998853)
23. van der Zee, J., Le Ber, I., Maurer-Stroh, S., Engelborghs, S., Gijselinck, I., Camuzat, A., Brouwers, N., Vandenberghe, R., Sleegers, K., Hannequin, D., Dermaut, B., Schymkowitz, J., Campion, D., Santens, P., Martin, J. J., Lacomblez, L., De Pooter, T., Peeters, K., Mattheijssens, M., Vercelletto, M., Van den Broeck, M., Cruts, M., De Deyn, P. P., Rousseau, F., Brice, A., and Van Broeckhoven, C. (2007) Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia. Hum. Mutat. 28, 416
24. Wang, J., Van Damme, P., Cruchaga, C., Gitcho, M. A., Vidal, J. M., Seijo-Martínez, M., Wang, L., Wu, J. Y., Robberecht, W., and Goate, A. (2010) Pathogenic cysteine mutations affect progranulin function and production of mature granulins. J. Neurochem. 112, 1305-1315
25. Mukherjee, O., Wang, J., Gitcho, M., Chakraverty, S., Taylor-Reinwald, L., Shears, S., Kauwe, J. S., Norton, J., Levitch, D., Bigio, E. H., Hatanpaa, K. J., White, C. L., Morris, J. C., Cairns, N. J., and Goate, A. (2008) Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia. Hum. Mutat. 29, 512-521 (Pubitemid 351536990)
26. Shankaran, S. S., Capell, A., Hruscha, A. T., Fellerer, K., Neumann, M., Schmid, B., and Haass, C. (2008) Missense mutations in the progranulin gene linked to frontotemporal lobar degeneration with ubiquitin-immunoreactive inclusions reduce progranulin production and secretion. J. Biol. Chem. 283, 1744-1753
27. Van Deerlin, V. M., Wood, E. M., Moore, P., Yuan, W., Forman, M. S., Clark, C. M., Neumann, M., Kwong, L. K., Trojanowski, J. Q., Lee, V. M., and Grossman, M. (2007) Clinical, genetic, and pathologic characteristics of patients with frontotemporal dementia and progranulin mutations. Arch. Neurol. 64, 1148-1153 (Pubitemid 47258074)
28. Van Deerlin, V. M., Sleiman, P. M., Martinez-Lage, M., Chen-Plotkin, A., Wang, L. S., Graff-Radford, N. R., Dickson, D. W., Rademakers, R., Boeve, B. F., Grossman, M., Arnold, S. E., Mann, D. M., Pickering-Brown, S. M., Seelaar, H., Heutink, P., van Swieten, J. C., Murrell, J. R., Ghetti, B., Spina, S., Grafman, J., Hodges, J., Spillantini, M. G., Gilman, S., Lieberman, A. P., Kaye, J. A., Woltjer, R. L., Bigio, E. H., Mesulam, M., Al-Sarraj, S., Troakes, C., Rosenberg, R. N., White, C. L., 3rd, Ferrer, I., Lladó, A., Neumann, M., Kretzschmar, H. A., Hulette, C. M., Welsh-Bohmer, K. A., Miller, B. L., Alzualde, A., Lopez de Munain, A., McKee, A. C., Gearing, M., Levey, A. I., Lah, J. J., Hardy, J., Rohrer, J. D., Lashley, T., Mackenzie, I. R., Feldman, H. H., Hamilton, R. L., Dekosky, S. T., van der Zee, J., Kumar-Singh, S., Van Broeckhoven, C., Mayeux, R., Vonsattel, J. P., Troncoso, J. C., Kril, J. J., Kwok, J. B., Halliday, G. M., Bird, T. D., Ince, P. G., Shaw, P. J., Cairns, N. J., Morris, J. C., McLean, C. A., DeCarli, C., Ellis, W. G., Freeman, S. H., Frosch, M. P., Growdon, J. H., Perl, D. P., Sano, M., Bennett, D. A., Schneider, J. A., Beach, T. G., Reiman, E. M., Woodruff, B. K., Cummings, J., Vinters, H. V., Miller, C. A., Chui, H. C., Alafuzoff, I., Hartikainen, P., Seilhean, D., Galasko, D., Masliah, E., Cotman, C. W., Tuñón, M. T., Martínez, M. C., Munoz, D. G., Carroll, S. L., Marson, D., Riederer, P. F., Bogdanovic, N., Schellenberg, G. D., Hakonarson, H., Trojanowski, J. Q., and Lee, V. M. (2010) Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat. Genet. 42, 234-239
29. Rollinson, S., Mead, S., Snowden, J., Richardson, A., Rohrer, J., Halliwell, N., Usher, S., Neary, D., Mann, D., Hardy, J., and Pickering-Brown, S. (2011) Frontotemporal lobar degeneration genome wide association study replication confirms a risk locus shared with amyotrophic lateral sclerosis. Neurobiol. Aging 32, 758 e751-757
30. Cruchaga, C., Graff, C., Chiang, H. H., Wang, J., Hinrichs, A. L., Spiegel, N., Bertelsen, S., Mayo, K., Norton, J. B., Morris, J. C., and Goate, A. (2011) Association of TMEM106B gene polymorphism with age at onset in granulin mutation carriers and plasma granulin protein levels. Arch. Neurol. 68, 581-586
31. Finch, N., Carrasquillo, M. M., Baker, M., Rutherford, N. J., Coppola, G., Dejesus-Hernandez, M., Crook, R., Hunter, T., Ghidoni, R., Benussi, L., Crook, J., Finger, E., Hantanpaa, K. J., Karydas, A. M., Sengdy, P., Gonzalez, J., Seeley, W. W., Johnson, N., Beach, T. G., Mesulam, M., Forloni, G.,Kertesz, A., Knopman, D. S., Uitti, R., White, C. L., 3rd, Caselli, R., Lippa, C., Bigio, E. H., Wszolek, Z. K., Binetti, G., Mackenzie, I. R., Miller, B. L., Boeve, B. F., Younkin, S. G., Dickson, D. W., Petersen, R. C., Graff-Radford, N. R., Geschwind, D. H., and Rademakers, R. (2011) TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Neurology 76, 467-474
32. van der Zee, J., Van Langenhove, T., Kleinberger, G., Sleegers, K., Engelborghs, S., Vandenberghe, R., Santens, P., Van den Broeck, M., Joris, G., Brys, J., Mattheijssens, M., Peeters, K., Cras, P., De Deyn, P. P., Cruts, M., and Van Broeckhoven, C. (2011) TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort. Brain 134, 808-815
33. van der Zee, J., and Van Broeckhoven, C. (2011) TMEM106B a Novel Risk Factor for Frontotemporal Lobar Degeneration. J. Mol. Neurosci.,
34. Capell, A., Liebscher, S., Fellerer, K., Brouwers, N., Willem, M., Lammich, S., Gijselinck, I., Bittner, T., Carlson, A. M., Sasse, F., Kunze, B., Steinmetz, H., Jansen, R., Dormann, D., Sleegers, K., Cruts, M., Herms, J., Van Broeckhoven, C., and Haass, C. (2011) Rescue of progranulin deficiency associated with frontotemporal lobar degeneration by alkalizing reagents and inhibition of vacuolar ATPase. J. Neurosci. 31, 1885-1894
35. Fujiki, Y., Hubbard, A. L., Fowler, S., and Lazarow, P. B. (1982) Isolation of intracellular membranes by means of sodium carbonate treatment: application to endoplasmic reticulum. J. Cell Biol. 93, 97-102 (Pubitemid 12117045)
36. Bonifacino, J. S., Dell'Angelica, E. C., and Springer, T. A. (2001) Immuno-precipitation. in Curr. Protoc. Protein Sci. Chapter 9, Unit 9.8
37. Rink, J., Ghigo, E., Kalaidzidis, Y., and Zerial, M. (2005) Rab conversion as a mechanism of progression from early to late endosomes. Cell 122, 735-749 (Pubitemid 41242638)
38. Da Cruz, S., and Cleveland, D. W. (2011) Understanding the role of TDP-43 and FUS/TLS in ALS and beyond. Curr. Opin. Neurobiol. 21, 904-919
39. Braulke, T., and Bonifacino, J. S. (2009) Sorting of lysosomal proteins. Biochim. Biophys. Acta 1793, 605-614
40. Saftig, P., and Klumperman, J. (2009) Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function. Nat. Rev. Mol. Cell Biol. 10, 623-635
41. van der Zee, J., Urwin, H., Engelborghs, S., Bruyland, M., Vandenberghe, R., Dermaut, B., De Pooter, T., Peeters, K., Santens, P., De Deyn, P. P., Fisher, E. M., Collinge, J., Isaacs, A. M., and Van Broeckhoven, C. (2008) CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro. Hum. Mol. Genet. 17, 313-322
42. Belly, A., Bodon, G., Blot, B., Bouron, A., Sadoul, R., and Goldberg, Y. (2010) CHMP2B mutants linked to frontotemporal dementia impair maturation of dendritic spines. J. Cell Sci. 123, 2943-2954
43. Urwin, H., Authier, A., Nielsen, J. E., Metcalf, D., Powell, C., Froud, K., Malcolm, D. S., Holm, I., Johannsen, P., Brown, J., Fisher, E. M., van der Zee, J., Bruyland, M., FReJA Consortium, Van Broeckhoven, C., Collinge, J., Brandner, S., Futter, C., and Isaacs, A. M. (2010) Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations. Hum. Mol. Genet. 19, 2228-2238
44. Hu, F., Padukkavidana, T., Vægter, C. B., Brady, O. A., Zheng, Y., Mackenzie, I. R., Feldman, H. H., Nykjaer, A., and Strittmatter, S. M. (2010) Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin. Neuron 68, 654-667
45. Filimonenko, M., Stuffers, S., Raiborg, C., Yamamoto, A., Malerød, L., Fisher, E. M., Isaacs, A., Brech, A., Stenmark, H., and Simonsen, A. (2007) Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease. J. Cell Biol. 179, 485-500 (Pubitemid 350074792)
46. Lee, J. A., and Gao, F. B. (2008) Roles of ESCRT in autophagy-associated neurodegeneration. Autophagy 4, 230-232
47. Rusten, T. E., and Simonsen, A. (2008) ESCRT functions in autophagy and associated disease. Cell Cycle 7, 1166-1172 (Pubitemid 351749268)
48. Bahr, B. A., and Bendiske, J. (2002) The neuropathogenic contributions of lysosomal dysfunction. J. Neurochem. 83, 481-489 (Pubitemid 35231802)
49. Lee, J. H., Yu, W. H., Kumar, A., Lee, S., Mohan, P. S., Peterhoff, C. M., Wolfe, D. M., Martinez-Vicente, M., Massey, A. C., Sovak, G., Uchiyama, Y., Westaway, D., Cuervo, A. M., and Nixon, R. A. (2010) Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer- related PS1 mutations. Cell 141, 1146-1158
50. Lee, S., Sato, Y., and Nixon, R. A. (2011) Lysosomal proteolysis inhibition selectively disrupts axonal transport of degradative organelles and causes an Alzheimer's-like axonal dystrophy. J. Neurosci. 31, 7817-7830
51. Nixon, R. A., and Yang, D. S. (2011) Autophagy failure in Alzheimer's disease-locating the primary defect. Neurobiol. Dis. 43, 38-45
52. Rubinsztein, D. C. (2006) The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443, 780-786